Connect Biopharma Holdings Ltd. (CNTB)
NASDAQ · Healthcare
Connect Biopharma Holdings Ltd. Shareholder Equity 2023–2025
Connect Biopharma Holdings Ltd. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Connect Biopharma Holdings Ltd. shareholder equity for the quarter ending December 31, 2025 were 42.0M, a 54.45% decrease year-over-year.
- Connect Biopharma Holdings Ltd. shareholder equity for 2025 were 42.0M, a 54.45% decrease from 2024.
- Connect Biopharma Holdings Ltd. shareholder equity for 2024 were 92.2M, a 9.19% decrease from 2023.
- Connect Biopharma Holdings Ltd. shareholder equity for 2023 were 101.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Connect Biopharma Holdings Ltd. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $42 |
| 2024 | $92 |
| 2023 | $101 |
| Connect Biopharma Holdings Ltd. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $42 |
| 2024-12-31 | $92 |
| 2023-12-31 | $101 |
Connect Biopharma Holdings Ltd. Shareholder Equity — FAQ
Connect Biopharma Holdings Ltd. (CNTB) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CNTB's shareholder equity history?
The chart and table above show Connect Biopharma Holdings Ltd.'s shareholder equity by year and by quarter, including the growth rate.